Your email has been successfully added to our mailing list.

×
0 0 0 -0.0838709677419354 -0.103225806451613 -0.064516129032258 -0.0643870967741935 -0.0709677419354838
Stock impact report

Agile Therapeutics +7% after resubmitting NDA for Twirla [Seeking Alpha]

Agile Therapeutics, Inc. (AGRX) 
Last agile therapeutics, inc. earnings: 5/2 04:15 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.agiletherapeutics.com/investor-relations
Company Research Source: Seeking Alpha
Agile Therapeutics +7% after resubmitting NDA for Twirla Agile Therapeutics (NASDAQ: AGRX resubmitted The Company resubmitted NDA in response to a December 2017 Complete Response Letter (CRL) which identified deficiencies relating to quality control adhesion test methods, facility inspection and in vivo Shares are up 7% Previously: Agile Therapeutics advancing Twirla, to refile U.S. marketing application next quarter Show less Read more
Impact Snapshot
Event Time:
AGRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for AGRX alerts
Opt-in for
AGRX alerts

from News Quantified
Opt-in for
AGRX alerts

from News Quantified